Skip to search.
 TSX Down 0.60% TSX Ventures Down 1.08%

AstraZeneca PLC (AZN)

-NYSE
65.12 Down 0.29(0.44%) 4:00PM EDT
Add to Portfolio
Prev Close:65.41
Open:64.81
Bid:65.10 x 700
Ask:65.11 x 900
1y Target Est:75.97
Beta:0.78
Next Earnings Date:N/A
Day's Range:64.73 - 65.38
52wk Range:63.22 - 76.57
Volume:979,950
Avg Vol (3m):1,355,380
Market Cap:82.31B
P/E (ttm):64.28
EPS (ttm):1.01
Div & Yield:3.80 (5.70%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 0.44%82.31B
GSKDown 0.73%101.31B
MRKDown 0.21%162.59B
PFEDown 0.36%204.74B

Key Statistics

Forward P/E (1 yr):15.96
P/S (ttm):3.22
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :4.21
Quarterly EPS Est (Jun-15) :1.03
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):5.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback